Predicting palbociclib efficacy in breast cancer with organoid-derived biomarkers

High DYNLT1 expression predicts poor response to 1L palbociclib in HR+ breast cancer

INDICATION
Breast
BIOMARKER
DYNLT1

Related cases

Grid of orange, blue, purple, and green square blocks with scattered black dots.

Mutational profiles and treatment resistance in metastatic TNBC

2026-03-27
Breast
PIK3CA
Abstract digital pattern with scattered black, blue, green, and purple dots on a white background.

Stratifying HR+ HER2- breast cancer through ER signaling and G2/M molecular signatures

2026-03-27
Breast
ER Signaling
Abstract grid of purple dots forming a diagonal pattern and a vertical line.

Impact of PIK3R1 loss-of-function on survival in metastatic breast cancer

2026-03-06
Breast
PIK3R1